Risk estimates for complex disorders: Comparing personal genome testing and family history

Genetics in Medicine

Volumn 16, Issue 3, 2014, Pages 231-237

  Aiyar, Lila ^a,c   Shuman, Cheryl ^a,b   Hayeems, Robin ^b,d   Dupuis, Annie ^b,e   Pu, Shuye ^b   Wodak, Shoshana ^b   Chitayat, David ^b,f   Velsher, Lea ^g   Davies, Jill ^g  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c KAPIOLANI MEDICAL CENTER FOR WOMEN AND CHILDREN   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f MOUNT SINAI HOSPITAL   (Canada)

^g Medcan Clinic   (Canada)

Author keywords

Complex diseases; Family history; Navigenics; Personal genome testing; Risk comparison; Risk estimates

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BREAST CANCER; COLON CANCER; DEEP VEIN THROMBOSIS; FAMILIAL CANCER; FAMILY ASSESSMENT; FAMILY HISTORY; FEMALE; GENETIC COUNSELING; GENETIC RISK; GENOME ANALYSIS; GLAUCOMA; GRAVES DISEASE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEMOCHROMATOSIS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; LACTOSE INTOLERANCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MELANOMA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOARTHRITIS; OVARY CANCER; PROSTATE CANCER; PSORIASIS; RESTLESS LEGS SYNDROME; RETINA MACULA DEGENERATION; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SEX DIFFERENCE; YOUNG ADULT; ADOLESCENT; BREAST NEOPLASMS; COLONIC NEOPLASMS; COMPARATIVE STUDY; FAMILY HEALTH; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; PERSONALIZED MEDICINE; PROCEDURES; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; VENOUS THROMBOSIS;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; BREAST NEOPLASMS; COLONIC NEOPLASMS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INDIVIDUALIZED MEDICINE; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84895812643     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2013.115     Document Type: Article

References (27)

1. Dvoskin R, Kaufman D. Tables of direct-To-consumer genetic testing companies and conditions tested. 2011. http://www.dnapolicy.org/resources/ DTCTableAug2011Alphabydisease.pdf. Accessed 1 October 2012
2. Yang Q, Flanders WD, Moonesinghe R, Ioannidis JP, Guessous I, Khoury MJ. Using lifetime risk estimates in personal genomic profiles: Estimation of uncertainty. Am J Hum Genet 2009;85:786-800
3. Ng PC, Murray SS, Levy S, Venter JC. An agenda for personalized medicine. Nature 2009;461:724-726
4. Swan M. Multigenic condition risk assessment in direct-To-consumer genomic services. Genet Med 2010;12:279-288
5. Caulfield T, Ries NM, Ray PN, Shuman C, Wilson B. Direct-To-consumer genetic testing: Good, bad or benign? Clin Genet 2010;77:101-105
6. Veenstra DL, Roth JA, Garrison LP Jr, Ramsey SD, Burke W. A formal riskbenefit framework for genomic tests: Facilitating the appropriate translation of genomics into clinical practice. Genet Med 2010;12:686-693
7. Burke W, Burton H, Hall AE, et al.; Ickworth Group. Extending the reach of public health genomics: What should be the agenda for public health in an era of genome-based and personalized medicine? Genet Med 2010;12:785-791
8. Burke W. Clinical validity and clinical utility of genetic tests. Curr Protoc Hum Genet 2009;Chapter 9:Unit 9.15
9. Sun J, Kader AK, Hsu FC, et al. Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer. Prostate 2011;71:421-430
10. Guttmacher AE, Collins FS, Carmona RH. The family history-more important than ever. N Engl J Med 2004;351:2333-2336
11. Scheuner MT, Wang SJ, Raffel LJ, Larabell SK, Rotter JI. Family history: A comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet 1997;71:315-324
12. Valdez R, Yoon PW, Qureshi N, Green RF, Khoury MJ. Family history in public health practice: A genomic tool for disease prevention and health promotion. Annu Rev Public Health 2010;31:69-87 1 p following 87
13. Bloss CS, Topol EJ, Schork NJ. Association of direct-To-consumer genome-wide disease risk estimates and self-reported disease. Genet Epidemiol 2012;36:66-70
14. Heald B, Edelman E, Eng C. Prospective comparison of family medical history with personal genome screening for risk assessment of common cancers. Eur J Hum Genet 2012;20:547-551
15. Navigenics. www.navigenics.com. Accessed 23 January 2011
16. Medcan Clinic. www.medcan.com/services/genetics/personal-genome-Testing. Accessed 23 January 2011
17. Navigenics. The science behind the Navigenics service. 1(866):1-13. http://www.navigenics.com/static/pdf/Navigenics-TheScience.pdf. Accessed 20 January 2011
18. Bennett RL, French KS, Resta RG, Doyle DL. Standardized human pedigree nomenclature: Update and assessment of the recommendations of the National Society of Genetic Counselors. J Genet Couns 2008;17: 424-433
19. Qiao L, Feng Y. Genetic variations of prostate stem cell antigen (PSCA) contribute to the risk of gastric cancer for Eastern Asians: A meta-Analysis based on 16792 individuals. Gene 2012;493:83-91
20. Navigenics. SNP Guide. Navigenics Practice Enhancement Kit. 2011
21. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174
22. Hogarth S, Javitt G, Melzer D. The current landscape for direct-To-consumer genetic testing: Legal, ethical, and policy issues. Annu Rev Genomics Hum Genet 2008;9:161-182
23. Eng C, Sharp RR. Bioethical and clinical dilemmas of direct-To-consumer personal genomic testing: The problem of misattributed equivalence. Sci Transl Med 2010;2(17):175
24. LaRusse S, Roberts JS, Marteau TM, et al. Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease. Genet Med 2005;7:48-53
25. Ozanne EM, O'Connell A, Bouzan C, et al. Bias in the reporting of family history: Implications for clinical care. J Genet Couns 2012;21:547-556
26. Mitchell RJ, Brewster D, Campbell H, et al. Accuracy of reporting of family history of colorectal cancer. Gut 2004;53:291-295
27. Janssens AC, Henneman L, Detmar SB, et al. Accuracy of self-reported family history is strongly influenced by the accuracy of self-reported personal health status of relatives. J Clin Epidemiol 2012;65:82-89